2026 Presentations

Clinical Research Coordinator Harini Somanchi, BS presents how the BRIDGES-NBS study team developed its condition list, which covers 777 conditions across 746 genetic changes, at ICoNS'26.

Building on G2P’s evidence base from the BabySeq and BRIDGES projects, Dr. Robert C. Green opened the 5th Annual International Consortium on Newborn Sequencing (ICoNS) meeting with a keynote charting the roadmap for translating preventative genomic screening into safe, population-level clinical and public health realities all across the world.

Dr. Robert C. Green delivers the Plenary Keynote at GA4GH, demonstrating how genomic sequencing can move from promising research studies into routine care for every newborn. Drawing on the BabySeq and BRIDGES-NBS projects, in addition to wider newborn-sequencing efforts, his talk considers what it will take to deliver screening that is clinically meaningful, responsibly manages … Continued

Dr. Nina Gold presents Long-term Penetrance of Disease Variants in Genes Prioritized for Genomic Newborn Screening: Evidence from adult biobanks, highlighting research on the penetrance of genetic variants associated with conditions prioritized for genomic newborn screening. In her talk, Dr. Gold explores how understanding variant penetrance can help inform the design and implementation of genomic … Continued

Robert C. Green, MD, MPH presents a Scientific Lecture Empirical Findings on the Path to Genomic Medicine in Newborns and Adults as part of the 2026 UC Irvine School of Medicine Dean's Distinguished Lecture Series on June 3rd at 12:00 PM PDT. Recording forthcoming.    

Vilma Kodyte, MS presents a community talk From a Drop of Blood to a World of Data: Is Public Health Ready for Genomic Newborn Sequencing? at the Salem Athenaeum on June 3rd at 7:00 PM EDT. In this talk, she shares an overview of the BEACONS-NBS research study, including its scientific goals, its ethical commitments, and … Continued

Robert C. Green, MD, MPH presents a Community Lecture Finally! Genomics is Delivering Massive Health and Longevity Benefits as part of the 2026 UC Irvine School of Medicine Dean's Distinguished Lecture Series on June 2nd at 7:00 PM PDT. Recording forthcoming.

Robert C. Green, MD, MPH presents the Keynote presentation Update on Newborn Sequencing in the US and Around the World at Labroots’ 14th Annual Precision Medicine: Genomics, Proteomics & Molecular Diagnostics Virtual Event Series 2026, on May 13th at 7:30 AM PDT. Join to learn about the latest advancements in genomics research and the promise it holds … Continued

Dr. Nina B. Gold, MD, MS, winner of last year’s MGfC Pilot and Feasibility award, presented Estimating the Lifelong Penetrance of Inherited Metabolic Disorders on May 5, at 9:20 AM EDT. Her talk featured exciting progress from her pilot study exploring how genetic conditions may impact individuals across the lifespan.

Harini Somanchi, BS presented the talk Selection of Genetic Conditions for the BEACONS-NBS Study: The First U.S. Multi-State Genomic Screening Initiative on May 5, at 9:40 AM EDT. Her talk described the process for selecting the conditions which will be included in the BEACONS-NBS multi-state genomic newborn screening study.

Anna Lewis, PhD is joined by Ben Neale, PhD for their discussion Grappling with ethical issues with sociobehavioral genomics, where they dive into the various ethical issues that emerge at the interface of genomics and society, as part of a community talk hosted by Bioethics@Broad.

Drs. Ingrid Holm and Nina Gold provide an overview on how whole genome sequencing can impact diagnostic newborn screening. Watch to learn how advances in genetic research could enable earlier, more precise diagnoses—and the ethical and clinical questions shaping how these technologies may be used in practice. View Dr. Holm's slides here. View Dr. Gold's … Continued